The impact of anti-TNFα agents on weight-related changes: new insights from a real-world pharmacovigilance study using the FDA adverse event reporting system (FAERS) database-Reference-Cited by-同舟云学术

The impact of anti-TNFα agents on weight-related changes: new insights from a real-world pharmacovigilance study using the FDA adverse event reporting system (FAERS) database

Published:2021-07-07 Issue:9 Volume:21 Page:1281-1290
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Mazhar Faizan¹,Battini Vera¹,Gringeri Michele¹,Pozzi Marco²,Mosini Giulia¹,Marran Albaraa Mohammed N.³,Akram Shahzad⁴,van Manen Robbert P.⁵,Radice Sonia¹,Clementi Emilio¹²,Carnovale Carla¹

Affiliation:

1. “Luigi Sacco” University Hospital, Università Di Milano, Milan, Italy

2. Scientific Institute, IRCCS E. Medea, Bosisio Parini, LC, Italy

3. Department of Pharmaceutical Care, Prince Mohammed Bin Nasser Hospital, Jizan, Saudi Arabia

4. Pharmaceutical Care Department, King Abdullah Specialist Children Hospital, King Abdul-Aziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia

5. Oracle Health Sciences, Kattendijke, The Netherlands

Funder

Regional Center of Pharmacovigilance of Lombardy

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2021.1948529

Reference51 articles.

1. Tumor Necrosis Factor‐Alpha: Role in Development of Insulin Resistance and Pathogenesis of Type 2 Diabetes Mellitus

2. The metabolic effects of tumor necrosis factor and other cytokines